Compare Stocks

Date Range: 

 Viemed HealthcareAsensus SurgicalItamar MedicalCreo MedicalTalis Biomedical
SymbolTSE:VMDNYSE:ASXCNASDAQ:ITMRLON:CREONASDAQ:TLIS
Price Information
Current PriceC$11.60$1.84$24.35GBX 200$11.59
52 Week RangeHoldHoldBuyN/ABuy
MarketRank™
Overall Score0.30.01.30.51.8
Analysis Score0.00.03.50.03.4
Community Score0.00.02.52.53.9
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.00.01.7
Earnings & Valuation Score1.30.00.60.00.0
Analyst Ratings
Consensus RecommendationHoldHoldBuyN/ABuy
Consensus Price TargetN/AN/A$31.00N/A$16.75
% Upside from Price TargetN/AN/A27.31% upsideN/A44.52% upside
Trade Information
Market CapC$459.10 million$428.40 million$392.23 million£315.88 million$297.14 million
BetaN/AN/A1.26N/AN/A
Average Volume159,74427,159,47338,073111,570270,377
Sales & Book Value
Annual RevenueC$135.92 millionN/A$31.26 million£8,154.00N/A
Price / Sales3.38N/A12.5538,739.27N/A
CashflowC$0.79 per shareN/AN/AGBX 44.17 per shareN/A
Price / Cash14.76N/AN/A4.53N/A
Book ValueC$2.11 per shareN/AN/AGBX 47.80 per shareN/A
Price / Book5.50N/A0.04N/A
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSC$0.87N/A($0.40)GBX (12.40)N/A
Trailing P/E Ratio13.350.00N/AN/A0.00
Forward P/E RatioN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio11.89%N/AN/A1.24%N/A
Current Ratio2.21%N/AN/A14.79%N/A
Quick Ratio2.03%N/AN/A14.62%N/A
Ownership Information
Institutional Ownership PercentageN/AN/A29.42%N/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees511128184175N/A
Shares Outstanding39.58 million232.83 million16.11 million157.94 million25.64 million
Next Earnings Date8/4/2021 (Estimated)5/11/2021 (Confirmed)5/19/2021 (Confirmed)N/A5/11/2021 (Confirmed)
OptionableNot OptionableOptionableNot OptionableNot OptionableNot Optionable
SourceHeadline
Talis Biomedical (TLIS) to Release Quarterly Earnings on TuesdayTalis Biomedical (TLIS) to Release Quarterly Earnings on Tuesday
americanbankingnews.com - May 5 at 10:56 AM
Talis Biomedical to Announce First Quarter 2021 Financial Results on May 11, 2021Talis Biomedical to Announce First Quarter 2021 Financial Results on May 11, 2021
finance.yahoo.com - May 4 at 10:31 AM
Talis Biomedical (NASDAQ:TLIS) Trading Up 0.1%Talis Biomedical (NASDAQ:TLIS) Trading Up 0.1%
americanbankingnews.com - April 29 at 12:50 AM
Talis Biomedical to Participate in Upcoming BofA Securities 2021 Virtual Healthcare ConferenceTalis Biomedical to Participate in Upcoming BofA Securities 2021 Virtual Healthcare Conference
finance.yahoo.com - April 28 at 10:15 AM
Talis Appoints Jeryl Hilleman to Board of DirectorsTalis Appoints Jeryl Hilleman to Board of Directors
finance.yahoo.com - March 18 at 8:27 AM
4 Stocks With High Insider Cluster Buys During February and March4 Stocks With High Insider Cluster Buys During February and March
finance.yahoo.com - March 16 at 6:44 PM
Talis Biomedical Corp.Talis Biomedical Corp.
barrons.com - March 12 at 7:03 PM
Talis Provides Update on Regulatory Pathway for Emergency Use Authorization (EUA) of its Talis One(TM) COVID-19 TestTalis Provides Update on Regulatory Pathway for Emergency Use Authorization (EUA) of its Talis One(TM) COVID-19 Test
marketwatch.com - March 9 at 4:06 PM
Benzingas Top Ratings Upgrades, Downgrades For March 9, 2021Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2021
finance.yahoo.com - March 9 at 4:06 PM
Talis Provides Update on Regulatory Pathway for Emergency Use Authorization (EUA) of its Talis ...Talis Provides Update on Regulatory Pathway for Emergency Use Authorization (EUA) of its Talis ...
omaha.com - March 9 at 11:06 AM
Talis Provides Update on Regulatory Pathway for Emergency Use Authorization (EUA) of its Talis One COVID-19 TestTalis Provides Update on Regulatory Pathway for Emergency Use Authorization (EUA) of its Talis One COVID-19 Test
wallstreet-online.de - March 8 at 12:37 PM
Talis Provides Update on Regulatory Pathway for Emergency Use Authorization (EUA) of its Talis One™ COVID-19 TestTalis Provides Update on Regulatory Pathway for Emergency Use Authorization (EUA) of its Talis One™ COVID-19 Test
finance.yahoo.com - March 8 at 12:37 PM
Monday 2/22 Insider Buying Report: TLIS, SONAMonday 2/22 Insider Buying Report: TLIS, SONA
nasdaq.com - February 22 at 2:10 PM
Talis Announces Closing of Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional SharesTalis Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
benzinga.com - February 19 at 7:52 PM
Talis Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to ...Talis Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to ...
apnews.com - February 17 at 7:49 PM
Talis Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesTalis Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - February 17 at 7:49 PM
Talis Biomedical CorpTalis Biomedical Corp
reuters.com - February 16 at 12:59 PM
DateCompanyBrokerageAction
10/19/2020Viemed HealthcareBloom BurtonReiterated Rating
3/16/2021Asensus SurgicalRaymond JamesReiterated Rating
3/15/2021Itamar MedicalHC WainwrightBoost Price Target
3/2/2021Itamar MedicalPiper SandlerBoost Price Target
10/14/2020Itamar MedicalAlliance Global PartnersBoost Price Target
8/3/2020Itamar MedicalCowenReiterated Rating
6/12/2020Itamar MedicalSVB LeerinkInitiated Coverage
8/6/2019Itamar MedicalLADENBURG THALM/SH SHInitiated Coverage
3/15/2021Talis BiomedicalBank of AmericaInitiated Coverage
3/15/2021Talis BiomedicalJPMorgan Chase & Co.Initiated Coverage
3/15/2021Talis BiomedicalBTIG ResearchInitiated Coverage
(Data available from 5/8/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.